This inventor holds 1 USPTO granted patent. Top assignee: Roche Diagnostics Operations, Inc.. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Viet Peter Grunert: Innovator in Rheumatoid Arthritis Assessment
Introduction
Viet Peter Grunert is a notable inventor based in Munich, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the assessment of rheumatoid arthritis. His innovative approach has the potential to enhance the accuracy of diagnosing this chronic condition.
Latest Patents
Grunert holds a patent for a method titled "Assessing rheumatoid arthritis by measuring anti-CCP and interleukin 6." This invention relates to a method that aids in the assessment of rheumatoid arthritis, specifically in determining its presence or absence in vitro. The method involves analyzing biochemical markers by measuring the concentrations of anti-CCP and interleukin 6 in a sample. The results are then correlated to ascertain the presence or absence of rheumatoid arthritis. To improve the assessment further, additional markers may also be determined alongside anti-CCP and interleukin 6. The invention includes a marker panel for diagnosing rheumatoid arthritis and teaches a kit for performing the method.
Career Highlights
Grunert is associated with Roche Diagnostics Operations, Inc., where he applies his expertise in medical diagnostics. His work focuses on developing innovative solutions that enhance the understanding and management of rheumatoid arthritis.
Collaborations
Some of his notable coworkers include Norbert Wild and Werner Zolg, who contribute to the collaborative efforts in advancing medical diagnostics.
Conclusion
Viet Peter Grunert's contributions to the field of rheumatoid arthritis assessment exemplify the impact of innovation in medical diagnostics. His patent and work at Roche Diagnostics Operations, Inc. highlight the importance of accurate diagnostic methods in improving patient care.